Molecular and Cellular Mechanisms in Heart Failure
Authors:
- Ilaria PuggiaIPIlaria Puggia
- Teisha J. RowlandTRTeisha J. Rowland
- Shelley D. MiyamotoSMShelley D. Miyamoto
- Gianfranco SinagraGSGianfranco Sinagra
- Luisa MestroniLMLuisa Mestroni
- 1 January 2018
- book chapter
- Published by Elsevier
- p. 3-19
Abstract
No abstract availableThis publication has 160 references indexed in Scilit:
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratodermaClinical Research in Cardiology, 2011
- Effects of Age and Heart Failure on Human Cardiac Stem Cell FunctionThe American Journal of Pathology, 2011
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsNew England Journal of Medicine, 2011
- Hypertrophic Cardiomyopathy in ChildhoodHeart Failure Clinics, 2010
- The Pediatric Cardiomyopathy Registry and Heart Failure: Key Results from the First 15 YearsHeart Failure Clinics, 2010
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2010
- Sarcomere Gene Mutations in Hypertrophy and Heart FailureJournal of Cardiovascular Translational Research, 2010
- Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 GeneThe American Journal of Human Genetics, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007